sacituzumab
gilead sciences
['breast', 'choice i', 'sacituzumab', 'sacitu, govi', 'tropics-02']
just in: overall survival results from the
phase ili tropics-02 study of
sacituzumab govitecan vs treatment
of physician's choice in patients
with hr+/her2- metastatic breast cancer #esmo22 presented by dr hope rugo 
MD, PhD, Medical Oncologist, interests #breastcancer #bcsm #gyncsm #ImmunoOnc #Immunotherapy #biomarkers #clinicaltrials @ASCO Views my own.